Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAK-875 as add-on to glimepiride in type 2 diabetes
NCT01829477Phase 3Terminated
- Sponsor
- Takeda
- Start
- Apr 2013
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of fasiglifam in type 2 diabetes mellitus (T2DM), sponsored by Takeda. Started Apr 2013; status: terminated.
02
Drugs
fasiglifam
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01829477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01829477.